{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:09:01Z","timestamp":1757704141359,"version":"3.37.3"},"reference-count":37,"publisher":"Informa UK Limited","issue":"20","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2024,6,23]]},"DOI":"10.1080\/14796694.2024.2340422","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:48:29Z","timestamp":1725446909000},"page":"1401-1413","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Regorafenib in patients with metastatic colorectal cancer in Spain: from clinical trials to real-world evidence"],"prefix":"10.1080","volume":"20","author":[{"given":"Andres","family":"Cervantes","sequence":"first","affiliation":[{"name":"Medical Oncology Department, Biomedical Research Institute INCLIVA, Hospital Cl\u00ednico de Valencia, Universidad de Valencia, Valencia, Spain"},{"name":"CIBERONC, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Tabernero","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Vall d'Hebron Hospital Campus and\u00a0Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Garcia-Carbonero","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario 12 de Octubre, Imas12, UCM, CIBERONC, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Sastre","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Cl\u00ednico San Carlos, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Feliu","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario La Paz, IDIPAZ, CIBERONC, C\u00e1tedra UAM-AMGEN, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Carmen\u00a0Guill\u00e9n-Ponce","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Ram\u00f3n y Cajal, IRYCIS, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Garc\u00eda","family":"Paredes","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Cl\u00ednico San Carlos, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Carral","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital Universitario Lucus Augusti, Lugo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Hospital San Pedro de Alc\u00e1ntara, C\u00e1ceres, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"e_1_3_8_3_1","unstructured":"World Health Organization; International Agency for Research on Cancer. Globocan 2020 Spain cancer fact sheet. 2020. [accessed 2023 August 21]. Available at: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/724-spain-fact-sheets.pdf"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0106"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2017.03.019"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2018.11.002"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2021.07.008"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61900-X"},{"key":"e_1_3_8_10_1","unstructured":"European Medicines Agency. Stivarga (regorafenib) 40 mg film-coated tablets. Summary of product characteristics. 2023. [accessed 2023 August 21]. Available at: www.ema.europa.eu\/en\/documents\/product-information\/stivarga-epar-product-information_en.pdf"},{"key":"e_1_3_8_11_1","unstructured":"Bayer Healthcare Pharmaceuticals Inc. Stivarga(R) (regorafenib) US Prescribing Information. 2021. [accessed 2023 August 21]. Available at: www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/203085s011lbl.pdf"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0072"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.09.015"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7384-y"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0266"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2020.12.015"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-019-02279-5"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.650503"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00138-2"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq929"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2085-z"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv244"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190497"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-014-0352-7"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.09.037"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30272-4"},{"key":"e_1_3_8_27_1","unstructured":"U.S. National Library of Medicine. RE-SEARCH study: a study to learn how and in which amount regorafenib is given in usual practice to patients in Spain: a study looking back at cases that have already happened when the study begins. 2021. [accessed 2022 November 9]. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04920422"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100222"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12039"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2440-9"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.04.153"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000752"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-016-0458-1"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S255332"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30027-0"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.725"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb1609216"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.5625"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0647"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2024.2340422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T15:27:52Z","timestamp":1727278072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2024.2340422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":37,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024,6,23]]}},"alternative-id":["10.1080\/14796694.2024.2340422"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2024.2340422","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-03-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}